Antimitotic chalcones and related compounds as inhibitors of tubulin assembly

Anti-Cancer Agents in Medicinal Chemistry

Volumn 9, Issue 3, 2009, Pages 336-347

  Ducki, Sylvie ^a,b  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b UNIVERSITY OF SALFORD   (United Kingdom)

Author keywords

Antimitotic; Chalcone; Cytotoxic; Microtubule; Tubulin

Indexed keywords

1 AROYLINDOLE; 3 AROYL 2 ARYLBENZO[B] THIOPENE DERIVATIVE; 3 BENZOYLINDOLE; 3,5 DIARYLPYRAZOLE DERIVATIVE; 4 HYDROXYPHENYLBUTENONE; ALPHA METHYL CHALCONE; AMINOCHALCONE; AURONE; BENZOSUBERONE; BPROL 075; BROMOCHALCONE; CHALCONE DERIVATIVE; CHLOROCHALCONE; COMBRETASTATIN A4; COMBRETASTATIN A4 PHOSPHATE; FLUOROCHALCONE; HEXOBARBITAL; INDANOCINE; INDANONE; OXI 6196; OXIGENE; PHENSTATIN; SD 400; SEMAXANIB; TETRALONE; TUBULIN; UNCLASSIFIED DRUG;

CELL PROLIFERATION; CONFORMATIONAL TRANSITION; CYTOTOXICITY; DRUG DESIGN; DRUG MECHANISM; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG STRUCTURE; HUMAN; IC 50; MICROTUBULE ASSEMBLY; MITOSIS INHIBITION; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION; TUMOR;

EID: 65549090501     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871520610909030336     Document Type: Review

References (49)

1. Ducki, S.; Forrest, R.; Hadfield, J. A.; Kendall, A.; Lawrence, N. J.; McGown, A. T.; Rennison, D. Potent antimitotic and cell growth inhibitory properties of substituted chalcones. Bioorg. Med. Chem. Lett., 1998, 8(9), 1051-1056.
2. Lawrence, N. J.; McGown, A. T.; Ducki, S.; Hadfield, J. A. The interaction of chalcones with tubulin. Anti-Cancer Drug Des., 2000, 15(2), 135-141.
3. Hadfield, J. A.; Ducki, S.; Hirst, N.; McGown, A. T. Tubulin and microtubules as targets for anticancer drugs. Prog. Cell Cycle Res., 2003, 5, 309-325.
4. Ducki, S.; Mackenzie, G.; Lawrence, N. J.; Snyder, J. P. Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly. J. Med. Chem., 2005, 48(2), 457-465.
5. Pati, H. N.; Holt Jr., H. L.; LeBlanc, R.; Dickson, J.; Stewart, M.; Brown, T.; Lee, M. Synthesis and cytotoxic properties of nitro- and aminochalcones. Med. Chem. Res., 2005, 14(1), 19-25.
6. Lawrence, N. J.; Patterson, R. P.; Ooi, L.-L.; Cook, D.; Ducki, S. Effects of [alpha]-substitutions on structure and biological activity of anticancer chalcones. Bioorg. Med. Chem. Lett., 2006, 16(22), 5844-5848.
7. Kerr, D. J.; Hamel, E.; Jung, M. K.; Flynn, B. L. The concise synthesis of chalcone, indanone and indenone analogues of combretastatin A4. Bioorg. Med. Chem., 2007, 15(9), 3290-3298.
8. Pinney, K. G.; Bounds, A. D.; Dingeman, K. M.; Mocharla, V. P.; Pettit, G. R.; Bai, R.; Hamel, E. A new anti-tubulin agent containing the benzo[b]thiophene ring system. Bioorg. Med. Chem. Lett., 1999, 9(8), 1081-1086.
9. Flynn, B. L.; Flynn, G. P.; Hamel, E.; Jung, M. K. The synthesis and tubulin binding activity of thiophene-based analogues of combretastatin A-4. Bioorg. Med. Chem. Lett., 2001, 11(17), 2341-2343.
10. Flynn, B. L.; Hamel, E.; Jung, M. K. One-pot synthesis of benzo[b]furan and indole inhibitors of tubulin polymerization. J. Med. Chem., 2002, 45(12), 2670-2673.
11. Quintin, J.; Roullier, C.; Thoret, S.; Lewin, G. Synthesis and anti-tubulin evaluation of chromone-based analogues of combretastatins. Tetrahedron, 2006, 62(17), 4038-4051.
12. Mailliet, P.; Capet, M.; Tiraboschi, G.; Caulfield, T. Preparation of substituted aroylacycloalkanes as tubulin polymerization inhibitors. WO2003048096, 2003.
13. Carson, D.; Shih, H.; Cottam, H.; Leoni, L. Indanone and tetralone compounds for inhibiting cell proliferation. WO9925335, 1998.
14. Lawrence, N. J.; Rennison, D.; McGown, A. T.; Hadfield, J. A. The total synthesis of an aurone isolated from Uvaria hamiltonii: aurones and flavones as anticancer agents. Bioorg. Med. Chem. Lett., 2003, 13(21), 3759-3763.
15. Álvarez, C.; Álvarez, R.; Corchete, P.; Pérez-Melero, C.; Peláez, R.; Medarde, M. Synthesis and biological activity of naphthalene analogues of phenstatins: Naphthylphenstatins. Bioorg. Med. Chem. Lett., 2007, 17(12), 3417-3420.
16. Sriram, M.; Hall, J. J.; Grohmann, N. C.; Strecker, T. E.; Wootton, T.; Franken, A.; Trawick, M. L.; Pinney, K. G. Design, synthesis and biological evaluation of dihydronaphthalene and benzo-suberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy. Bioorg. Med. Chem., 2008, (in press).
17. Romagnoli, R.; Baraldi, P. G.; Jung, M. K.; Iaconinoto, M. A.; Carrion, M. D.; Remusat, V.; Preti, D.; Tabrizi, M. A.; Francesca, F.; De Clercq, E.; Balzarini, J.; Hamel, E. Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles. Bioorg. Med. Chem. Lett., 2005, 15(18), 4048-4052.
18. Romagnoli, R.; Baraldi, P. G.; Carrion, M. D.; Cara, C. L.; Preti, D.; Fruttarolo, F.; Pavani, M. G.; Tabrizi, M. A.; Tolomeo, M.; Grimaudo, S.; Di Cristina, A.; Balzarini, J.; Hadfield, J. A.; Brancale, A.; Hamel, E. Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization. J. Med. Chem., 2007, 50(9), 2273-2277.
19. Romagnoli, R.; Baraldi, P. G.; Sarkar, T.; Carrion, M. D.; Cara, C. L.; Cruz-Lopez, O.; Preti, D.; Tabrizi, M. A.; Tolomeo, M.; Grimaudo, S.; Di Cristina, A.; Zonta, N.; Balzarini, J.; Brancale, A.; Hsieh, H. P.; Hamel, E. Synthesis and biological evaluation of 1-methyl-2-(3′,4′, 5′-trimethoxybenzoyl)-3-aminoindoles as a new class of antimitotic agents and tubulin inhibitors. J. Med. Chem., 2008, 51(5), 1464-1468.
20. Romagnoli, R.; Baraldi, P. G.; Sarkar, T.; Carrion, M. D.; Cruz-Lopez, O.; Cara, C. L.; Tolomeo, M.; Grimaudo, S.; Cristina, A. D.; Pipitone, M. R.; Balzarini, J.; Gambari, R.; Ilaria, L.; Saletti, R.; Brancale, A.; Hamel, E. Synthesis and biological evaluation of 2-(3′,4′,5′-Trimethoxybenzoyl)-3-N,N-Dimethylamino Benzo[b]-furan derivatives as inhibitors of tubulin polymerization. Bioorg. Med. Chem., 2008, (in press).
21. Li, L.; Wang, H.-K.; Kuo, S.-C.; Wu, T.-S.; Mauger, A.; Lin, C. M.; Hamel, E.; Lee, K.-H. Antitumor Agents 155. Synthesis and biological evaluation of 3′,6,7-substituted 2-phenyl-4-quinolones as antimicrotubule agents. J. Med. Chem., 1994, 37(20), 3400-3407.
22. Xia, Y.; Yang, Z. Y.; Xia, P.; Hackl, T.; Hamel, E.; Mauger, A.; Wu, J. H.; Lee, K. H. Antitumor agents 211. fluorinated 2-phenyl-4-quinolone derivatives as antimitotic antitumor agents1. J. Med. Chem., 2001, 44(23), 3932-3936.
23. Pandit, B.; Sun, Y.; Chen, P.; Sackett, D. L.; Hu, Z.; Rich, W.; Li, C.; Lewis, A.; Schaefer, K.; Li, P.-K. Structure-activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416. Bioorg. Med. Chem., 2006, 14(19), 6492-6501.
24. Liou, J. P.; Chang, Y. L.; Kuo, F. M.; Chang, C. W.; Tseng, H. Y.; Wang, C. C.; Yang, Y. N.; Chang, J. Y.; Lee, S. J.; Hsieh, H. P. Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents. J. Med. Chem., 2004, 47(17), 4247-4257.
25. Liou, J. P.; Wu, Z. Y.; Kuo, C. C.; Chang, C. Y.; Lu, P. Y.; Chen, C. M.; Hsieh, H. P.; Chang, J. Y. Discovery of 4-amino and 4-hydroxy-1-aroylindoles as potent tubulin polymerization inhibitors. J. Med. Chem., 2008, 51(14), 4351-4355.
26. Duan, J. X.; Cai, X.; Meng, F.; Lan, L.; Hart, C.; Matteucci, M. Potent antitubulin tumor cell cytotoxins based on 3-aroyl indazoles. J. Med. Chem., 2007, 50(5), 1001-1006.
27. Johnsona, M.; Younglovea, B.; Leea, L.; LeBlancb, R.; Jr., H. H.; Hillsd, P.; Mackayb, H.; Brownb, T.; Mooberryd, S. L.; Leea, M. Design, synthesis, and biological testing of pyrazoline derivatives of combretastatin-A4. Bioorg. Med. Chem. Lett., 2007, 17(21), 5897-5901.
28. Lee, L.; Davis, R.; Vanderham, J.; Hills, P.; Mackay, H.; Brown, T.; Mooberry, S. L.; Lee, M. 1,2,3,4-Tetrahydro-2-thioxopyrimidine analogs of combretastatin-A4. Eur. J. Med. Chem., (in press).
29. Edwards, M. L.; Stemerick, D. M.; Sunkara, P. S. Chalcones - a new class of antimitotic agents. J. Med. Chem., 1990, 33(7), 1948-1954.
30. Ducki, S.; Hadfield, J. A.; Lawrence, N. J.; Liu, C. Y.; McGown, A. T.; Zhang, X. Isolation of E-1-(4′-hydroxyphenyl)-but-1-en-3-one from Scutellaria barbata. Planta Med., 1996, 62(2), 185-186.
31. Ducki, S.; Hadfield, J. A.; Hepworth, L. A.; Lawrence, N. J.; Ching-Ying, L.; McGown, A. T. Synthesis and cell growth inhibitory properties of substituted (E)-1-phenylbut-1-en-3-ones. Bioorg. Med. Chem. Lett., 1997, 7(24), 3091-3094.
32. Lawrence, N. J.; Rennison, D.; McGown, A. T.; Ducki, S.; Gul, L. A.; Hadfield, J. A.; Khan, N. Linked parallel synthesis and MTT bioassay screening of substituted chalcones. J. Comb. Chem., 2001, 3(5), 421-426.
33. Boumendjel, A.; Boccard, J.; Carrupt, P.; Nicolle, E.; Blanc, M.; Geze, A.; Choisnard, L.; Wouessidjewe, D.; Matera, E.; Dumontet, C. Antimitotic and antiproliferative activities of chalcones: Forward structure-activity relationship. J. Med. Chem., 2008, 51(7), 2307-2310.
34. Rose, S. D.; Hartman, R. F. Modified Chalcone Compounds as Antimitotic Agents. Patent WO 2007/133588 A2, 2007.
35. Liu, X.; Go, M.-L. Antiproliferative properties of piperidinylchalcones. Bioorg. Med. Chem., 2006, 14, 153-163.
36. Peyrot, V.; Leynadier, D.; Sarrazin, M.; Briand, C.; Menendez, M.; Laynez, J.; Andreu, J. M. Mechanism of binding of the new antimitotic drug Mdl-27048 to the colchicine site of tubulin - equilibrium studies. Biochemistry, 1992, 31(45), 11125-11132.
37. Mailliet, P.; Combeau, C.; Bissery, M.-C.; Cherrier, M.-P.; Caulfield, T.; Tiraboschi, G. 1,3-Diarylprop-2-en-1-ones, compositions containing same and use thereof. WO 03/048106, 2003.
38. D'Amato, R. J.; Lin, C. M.; Flynn, E.; Folkman, J.; Hamel, E. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc. Natl. Acad. Sci. USA, 1994, 91(9), 3964-3968.
39. Mullica, D.; Pinney, K.; Mocharla, V.; Dingeman, K.; Bounds, A.; Sappenfield, E. Characterization and structural analyses of trimethoxy and triethoxybenzo[b]thiophene. J. Chem. Crystallogr., 1998, 28(4), 289-295.
40. Xu, J.; Ma, L.; Jiao, P. Asymmetric aziridination of chalcones catalyzed by a novel backbone 1,8-bisoxazolinylanthracene (An-BOX)-copper complex. J. Chem. Soc., Chem. Commun., 2004, 1616-1617.
41. Shih, H.; Deng, L.; Carrera, C. J.; Adachi, S.; Cottam, H. B.; Carson, D. A. Rational design, synthesis and structure-activity relationships of antitumor (E)-2-benzylidene-1-tetralones and (E)-2-benzylidene-1-indanones. Bioorg. Med. Chem. Lett., 2000, 10(5), 487-490.
42. Dimmock, J. R.; Kandepu, N. M.; Nazarali, A. J.; Kowalchuk, T. P.; Motaganahalli, N.; Quail, J. W.; Mykytiuk, P. A.; Audette, G. F.; Prasad, L.; Perjesi, P.; Allen, T. M.; Santos, C. L.; Szydlowski, J.; De Clercq, E.; Balzarini, J. Conformational and quantitative structure-activity relationship study of cytotoxic 2-arylidenebenzocycloalkanones. J. Med. Chem., 1999, 42(8), 1358-1366.
43. Dupeyre, G.; Chabot, G. G.; Thoret, S.; Cachet, X.; Seguin, J.; Guenard, D.; Tillequin, F.; Scherman, D.; Koch, M.; Michel, S. Synthesis and biological evaluation of (3,4,5-trimethoxyphenyl) indol-3-ylmethane derivatives as potential antivascular agents. Bioorg. Med. Chem., 2006, 14(13), 4410-4426.
44. Ty, N.; Dupeyre, G.; Chabot, G. G.; Seguin, J.; Tillequin, F.; Scherman, D.; Michel, S.; Cachet, X. Synthesis and biological evaluation of new disubstituted analogues of 6-methoxy-3-(3′,4′,5′-trimethoxybenzoyl)-1H-indole (BPR0L075), as potential antivascular agents. Bioorg. Med. Chem., 2008, 16(15), 7494-7503.
45. Kuo, C. C.; Hsieh, H. P.; Pan, W. Y.; Chen, C. P.; Liou, J. P.; Lee, S. J.; Chang, Y. L.; Chen, L. T.; Chen, C. T.; Chang, J. Y. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo. Cancer Res., 2004, 64(13), 4621-4628.
46. Liou, J. P.; Wu, C. Y.; Hsieh, H. P.; Chang, C. Y.; Chen, C. M.; Kuo, C. C.; Chang, J. Y. 4- And 5-aroylindoles as novel classes of potent antitubulin agents. J. Med. Chem., 2007, 50(18), 4548-4552.
47. LeBlanc, R.; Dickson, J.; Brown, T.; Stewart, M.; Pati, H. N.; VanDerveer, D.; Arman, H.; Harris, J.; Pennington, W.; Holt, J. H. L.; Lee, M. Synthesis and cytotoxicity of epoxide and pyrazole analogs of the combretastatins. Bioorg. Med. Chem., 2005, 13(21), 6025-6034.
48. Johnson, M.; Younglove, B.; Lee, L.; LeBlanc, R.; Jr., H. H.; Hills, P.; Mackay, H.; Brown, T.; Mooberry, S. L.; Lee, M. Design, synthesis, and biological testing of pyrazoline derivatives of combretastatin-A4 Bioorg. Med. Chem. Lett., 2007, 17(21), 5897-5901.
49. Tron, G. C.; Pirali, T.; Sorba, G.; Pagliai, F.; Busacca, S.; Genazzani, A. A. Medicinal chemistry of combretastatin A4: Present and future directions. J. Med. Chem., 2006, 49(11), 3033-3044.